BBIXF (Bonus BioGroup) Buyback Yield %: -3.03 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBIXF Bonus BioGroup Ltd BBIXF
21 GF Score
Price $0.10
! 3 Warning Signs
View Full Analysis

What is Bonus BioGroup Buyback Yield %?

Bonus BioGroup BBIXF 21 Buyback Yield % is -3.03 as of Jul. 19, 2026. GuruFocus rates BBIXF with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 740 Biotechnology companies, Bonus BioGroup ranks better than 65.95% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Bonus BioGroup's current buyback yield was -3.03%.

Bonus BioGroup Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Bonus BioGroup's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonus BioGroup Buyback Yield % Chart

Bonus BioGroup Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.47 -1.88 0.00 -5.42 -3.49

Bonus BioGroup Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -2.77 -1.35 -3.38

BBIXF vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Bonus BioGroup's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bonus BioGroup Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bonus BioGroup's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Bonus BioGroup's Buyback Yield % falls into.


BBIXF
21GF Score
Bonus BioGroup Ltd BBIXF
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonus BioGroup Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Bonus BioGroup's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 3.261) / 93.434
=-3.49%

Bonus BioGroup's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 3.261) / 93.434
=-3.49%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -3.03 mean?
Bonus BioGroup (BBIXF) has a Buyback Yield % of -3.03 as of Jul. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Bonus BioGroup and its competitors. According to the industry distribution chart, Bonus BioGroup ranks #252 out of 740 companies in the Biotechnology industry, placing it in the top 34.1%.
Is Bonus BioGroup's Buyback Yield % too high?
Bonus BioGroup's current Buyback Yield % is -3.03. Based on the distribution chart, Bonus BioGroup ranks #252 out of 740 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bonus BioGroup has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Bonus BioGroup's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bonus BioGroup ranks #252 out of 740 companies for Buyback Yield %. This puts Bonus BioGroup in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Bonus BioGroup and its competitors. Bonus BioGroup's current Buyback Yield % is -3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonus BioGroup stock overvalued right now?
Bonus BioGroup (BBIXF) has a current Buyback Yield % of -3.03. The current Buyback Yield % is -3.03. Bonus BioGroup's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Bonus BioGroup (BBIXF), the current Buyback Yield % is -3.03 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bonus BioGroup Business Description

Other Exchanges BONS:Israel
Address Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.
21GF Score

Get the complete analysis for BBIXF

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price